Clinical trial
Prevention of Milk-Borne Transmission of HIV-1C in Botswana
NCT00197587 · Harvard School of Public Health (HSPH), Other · Completed
Key facts
| NCT number | NCT00197587 |
|---|---|
| Title | Prevention of Milk-Borne Transmission of HIV-1C in Botswana |
| Official title | Prevention of Milk-Borne Transmission of HIV-1C in Botswana ("Mashi") |
| Acronym | Mashi |
| Lead sponsor | Harvard School of Public Health (HSPH), Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infection, Infant Risk for HIV Infection by MTCT |
| Intervention type | Drug |
| Interventions | Nevirapine, No intervention |
| Enrollment | 1,200 |
| Start date | Aug 1, 2002 |
| Primary completion | May 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | May 20, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: